You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Is Greater Coffee Consumption in Severe Hypertension Linked to Cardiovascular Disease Mortality?

  • Authors: News Author: Marilynn Larkin; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 2/10/2023
  • Valid for credit through: 2/10/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for cardiologists, family medicine/primary care clinicians, internists, geriatricians, public health and prevention officials, nurses, pharmacists, physician assistants, and other members of the health care team for patients with severe hypertension.

The goal of this activity is for learners to be better able to describe the associations of coffee and green tea consumption with cardiovascular disease mortality among people with severe hypertension and across multiple blood pressure categories, based on findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk, a large, long‐term, prospective cohort study of Japanese men and women.

Upon completion of this activity, participants will:

  • Assess the associations of coffee and green tea drinking with cardiovascular disease mortality among people with severe hypertension and across multiple blood pressure categories, based on findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk
  • Evaluate the clinical and public health implications of the associations of coffee and green tea drinking with cardiovascular disease mortality among people with severe hypertension and across multiple blood pressure categories, based on findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Marilynn Larkin

    Freelance writer, Medscape

    Disclosures

    Marilynn Larkin has no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has the following relevant financial relationships:
    Formerly owned stocks in: AbbVie Inc.

Editor/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-051-H01-P).

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 02/10/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Is Greater Coffee Consumption in Severe Hypertension Linked to Cardiovascular Disease Mortality?

Authors: News Author: Marilynn Larkin; CME Author: Laurie Barclay, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 2/10/2023

Valid for credit through: 2/10/2024, 11:59 PM EST

processing....

Clinical Context

Among the general population, coffee drinking may lower risk for incident hypertension (HTN) and mortality. However, among people with HTN, it may increase blood pressure (BP) in the short‐term. An experimental study suggested that the preventive effect of caffeinated coffee drinking depends on BP level and applies only to people without severe HTN.

Drinking caffeinated green tea lowers BP among people with pre-HTN and stage 1 HTN. Evidence suggests that it also reduces cardiovascular disease (CVD) and all-cause mortality among those with CVD and the general population.

Study Synopsis and Perspective

Individuals with severe HTN who drink 2 or more cups of coffee a day have double the long-term risk for death from CVD compared with those who do not consume coffee, suggest data from a population-based cohort study conducted in Japan.

The analysis explored whether the possible cardioprotective effects of coffee and green tea intake seen in epidemiologic studies apply regardless of BP, across different degrees of HTN severity, lead author Masayuki Teramoto, MD, MPH, from the University of California, San Francisco, told theheart.org | Medscape Cardiology.

Dr Teramoto said that he was surprised that “heavy” coffee consumption (at least 2 cups daily) was associated with increased CVD mortality among people with severe HTN but not those with normal BP or grade 1 HTN.

“In contrast,” he said, “green tea consumption was not associated with an increased risk of CVD mortality across all [BP] categories” in the analysis, which was based on more than 18,000 men and women in Japan who were followed for a median of 19 years.

Previous research has shown that greater coffee intake may cut the risk for incident HTN and mortality among the general population, but it can also increase BP over the short term among persons with HTN, Dr Teramoto noted. The protective effects, therefore, appear to depend on the individual’s BP.

“Because hypertensives are more susceptible to the effects of caffeine,” he said, “caffeine’s harmful effects may outweigh its protective effects and increase the risk of mortality in persons with severe [HTN].”

Dr Teramoto is lead author on the study, published online December 21 in the Journal of the American Heart Association.

No Increased Risk From Green Tea

The analysis was based on data from 18,609 participants (including 65% women) in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk study, which enrolled people aged 40 to 75 years living throughout Japan. The participants completed self-reported questionnaires on their medical history, diet, and lifestyle.

Their baseline BP was classified into 5 categories: optimal and normal (<130/85 mm Hg); high normal (130-139/85-89 mm Hg); grade 1 HTN (140-159/90-99 mm Hg); grade 2 HTN (160-179/100-109 mm Hg), and grade 3 HTN (>180/110 mm Hg).

Because of the low percentage of participants with grade 3 HTN, the grade 2 and 3 categories were combined into “severe” HTN.

Participants were asked in a survey about the frequency and amount of coffee and green tea they consumed and were classified into 4 levels of daily coffee consumption (occasionally or none, less than 1 cup, 1 cup, or 2 or more cups) and 6 levels of daily green tea consumption (occasionally or none, less than 1 cup, 1 to 2 cups, 3 to 4 cups, 5 to 6 cups, or 7 or more cups).

A total of 842 participants died during a median follow-up of 19 years.

Greater coffee consumption was associated with increased risk for CVD mortality only among participants with grade 2 to 3 HTN at an intake of 2 or more cups per day. The adjusted hazard ratio was 2.05 (95% CI, 1.17-3.59) compared with participants with severe HTN who did not drink coffee.

No associations between coffee consumption and CVD death were observed among participants with optimal/normal or high-normal BP or with grade 1 HTN.

Green tea consumption was not associated with an increased risk for CVD across any BP categories. However, among people with grade 2 to 3 HTN, frequent green tea consumption was associated with a lower total cholesterol level.

Statistical Challenges

“These are very interesting findings, because for the last decade or more, studies like these. . .have very consistently concluded there are benefits to both types of beverages,” American Heart Association Nutrition Committee chair Christopher Gardner, PhD, told theheart.org | Medscape Cardiology.

“What was unique about this study was the extra step of looking separately at 4 ranges of blood pressure.”

But he also expressed some concerns and caveats. For example, there were numerous participant subcategories by both BP and coffee consumption, such that “the rate of CVD mortality in the group of heavy coffee drinkers among participants with severe [HTN] was determined from just 19 events.” That makes up only 2% of CVD deaths. “This limits how robust the findings are.”

Also, the hazard ratio CIs for risk in patients with severe HTN consuming at least 2 cups coffee daily were wide. The 2-fold increased risk “could have been as little as a 17% increase in risk. . .or as much as a 3-fold risk,” Dr Gardner said.

Dr Gardner also noted the study’s failure to account for additives to coffee and tea drinks. For example, black coffee and a mocha frappe or cappuccino “might both qualify as coffee, but the latter is a sugar and saturated fat delivery vehicle.” Similarly, green tea and bubble tea both potentially qualify as tea, “but the latter is more of a tea-flavored beverage with sugar and dairy and other additives.”

Omission of this information raises concern, he said, that the study may encourage consumers with no or mild HTN to increase their consumption of potentially harmful coffee-like and tea-like beverages.

There are no daily nutritional requirements for coffee, tea, or caffeine, Dr Gardner said, “suggesting that adults with severe [HTN who] limit their coffee to 1 cup per day would not [experience] any nutrient deficiencies.”

The risk-benefit ratio for coffee intake and CVD mortality implied by the study “probably falls in line with recommending they limit their coffee consumption to less than 2 cups per day, until more results are available.”

The Japan Collaborative Cohort Study for Evaluation of Cancer Risk study was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare, Health and Labor Sciences, Japan; the National Cancer Center Research and Development Fund; and the Japan Society for the Promotion of Science. The authors and Dr Gardner have disclosed no relevant financial relationships.

J Am Heart Assoc. Published online December 21, 2022.[1]

Study Highlights

  • In the Japan Collaborative Cohort Study for Evaluation of Cancer Risk, 18,609 participants (6574 men) aged 40 to 79 years at baseline completed a lifestyle, diet, and medical history questionnaire and health examinations and were followed up until 2009.
  • Participants were classified as having optimal and normal BP (<130/85 mm Hg), high‐normal BP (130-139/85-89 mm Hg), grade 1 HTN (140-159/90-99 mm Hg), and grade 2 (160-179/100-109 mm Hg) or grade 3 (>180/110 mm Hg) HTN.
  • Regardless of BP category, frequent coffee drinkers were more likely to be younger, current smokers, and current drinkers; to eat fewer vegetables; and to have higher total cholesterol and lower SBP.
  • During follow‐up (median, 18.9 years), there were 842 CVD deaths.
  • Cox proportional hazard modeling showed that coffee drinking was associated with increased risk for CVD mortality among people with grade 2 to 3 HTN, with multivariable aHRs of CVD mortality of 0.98 (95% CI, 0.67-1.43) for less than 1 cup/day, 0.74 (95% CI, 0.37-1.46) for 1 cup/day, and 2.05 (95% CI, 1.17-3.59) for 2 or more cups/day vs non-coffee-drinkers (P for trend=.09).
  • Associations were similar after further adjustment for potential confounding factors.
  • No such associations occurred among people with optimal-normal BP, high‐normal BP, and grade 1 HTN.
  • Green tea drinking was not associated with increased CVD risk across any BP categories.
  • Among people with grade 2 to 3 HTN, frequent green tea drinking was associated with lower total cholesterol.
  • The investigators concluded that heavy coffee drinking was associated with increased risk for CVD mortality among people with severe HTN, but not people without HTN or with grade 1 HTN.
  • In contrast, green tea consumption was not associated with increased CVD mortality risk across all BP categories.
  • The findings may support the assertion that people with severe HTN should avoid heavy coffee drinking.
  • Caffeinated coffee contains chlorogenic acid and other phenolic compounds, magnesium, and trigonelline, which lower serum cholesterol, improve endothelial function, and reduce inflammation in women with diabetes.
  • Habitual coffee drinkers may develop caffeine tolerance, decreasing caffeine’s adverse effects on CVD outcomes.
  • In the general population, transient BP elevation from caffeine may be offset by benefits of other coffee components and tolerance to caffeine.
  • However, caffeine’s harmful effects may outweigh coffee’s protective effects and increase mortality risk in people with severe HTN, who are more susceptible to the effects of caffeine.
  • Benefits of green tea may reflect the effect of (−)‐epigallocatechin3‐gallate, its most abundant polyphenol, which in animal studies significantly lowered BP, enhanced endothelial function, reduced oxidative stress, attenuated inflammation, and improved plasma lipid profile.
  • Study limitations include reliance on self‐report and only a single baseline assessment of beverage drinking; possible unmeasured factors or residual confounding, and observational design precluding causal inferences.

Clinical Implications

  • Heavy coffee drinking was associated with increased risk for CVD mortality among people with severe HTN, but not people without HTN or grade 1 HTN; green tea was not associated with increased CVD mortality risk in any BP categories.
  • Caffeine’s harmful effects may outweigh coffee’s protective effects and increase mortality risk in people with severe HTN, who are more susceptible to caffeine’s effects.
  • Implications for the Health Care Team: Members of the healthcare team should provide education on the possible effects of heavy coffee drinking, as the study findings may support the assertion that people with severe HTN should avoid it.

 

Earn Credit

  • Print